Found 6 matching trials
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease PHASE2 The goal of this clinical trial is to test the safety and potential benefit...
Show More Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Learn More & Join Trial
A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia EARLY_PHASE1 This is an investigator-initiated trial to evaluate the safety and efficacy...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma PHASE1 The purpose of this study is to determine if UF-KURE-BCMA (B-Cell Maturatio...
Show More Location
University Hospitals Cleveland Medical Center Seidman Cancer Center
Learn More & Join Trial
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma PHASE2 This is an open-label, single arm, multicenter, interventional study with D...
Show More Location
Hospital Clinico Universitario Salamanca
Learn More & Join Trial
Anti-BCMA Chimeric Antigen Receptor T Cells for Relapsed or Refractory Multiple Myeloma PHASE1 This is an open-label study to determine the safety of anti-B-cell maturati...
Show More Status
Active Not Recruiting
Location
University of California, San Francisco
Learn More & Join Trial
P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM) PHASE1 Phase 1 of the study is comprised of an open-label, single ascending dose (...
Show More Location
Banner MD Anderson Cancer Center
Learn More & Join Trial